Chandan Healthcare Limited · NSE:CHANDAN
Chandan Healthcare — Q3 FY26 Earnings Presentation
41 slides from Chandan Healthcare's earnings presentation, Feb 16, 2026
Slide 1: Chandan Healthcare Limited exchange filing cover letter
CHANDAN HEALTHCARE LIMITED Reg. Off. Add: Biotech Park, Sector-G, Jankipuram, Kursi Road, Lucknow-226021 CIN: L85110UP2003PLC193493 TELNO.: -8069366666 Email: secretarial@chandan.co.in www.chandandiagnostic.com Date: February 16, 2026 To, The Listing Department National Stock Exchange of India Ltd.
Slide 2: Investor Presentation Q3 & 9M FY26
Chandan Healthcare Limited Investor Presentation Q3 & 9M FY26
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the Presentation), which have been prepared by Chandan Healthcare (Chandan, The Company) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not
Slide 4: Management Comments On Q3 & 9M FY26 Financial Performance
Management Comments On Q3 & 9M FY26 Financial Performance Amar Singh Promoter, Chairman and Managing Director We delivered a steady performance in Q3 FY26 with Total Income of ₹65.77 Cr and EBITDA of ₹12.61 Cr, reflecting healthy operating momentum and improved efficiencies. Our continued focus on n
Slide 5: Q3 FY26 Consolidated Key Financials Highlights
Q3 FY26 Consolidated Key Financials Highlights Total Income EBITDA PAT EBITDA % PAT % 65.77 54.82 19.17% 16.54% 12.61 9.06 4.20 4.54 7.67% 6.90% Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY26 All Amount In ₹ Cr & Margins In % Investor Presentation 4
Slide 6: 9M FY26 Consolidated Key Financials Highlights
9M FY26 Consolidated Key Financials Highlights Total Income EBITDA PAT EBITDA % PAT % 203.27 20.95% 167.99 18.30% 42.59 30.73 20.14 9.91% 9.61% 16.15 9M FY25 9M FY26 9M FY25 9M FY26 9M FY25 9M FY26 All Amount In ₹ Cr & Margins In % Investor Presentation 5
Slide 7: Q3 & 9M FY26 Consolidated Profit & Loss Statement
Q3 & 9M FY26 Consolidated Profit & Loss Statement In ₹ Cr Particulars Q3 FY26 Q3 FY25 Y-O-Y 9M FY26 9Y FY25 Y-O-Y Operating Income 65.01 54.64 200.81 167.47 Other Income 0.77 0.17 2.45 0.51 Total Income 65.77 54.82 19.99% 203.27 167.99 21.00% Raw Material Expenses 30.05 25.73 98.94 77.20 Employee Be
Slide 8: Q3 FY26 Operational Highlights
Q3 FY26 Operational Highlights Strategic Fundraise to Support Strategic Partnership Expansion and Acquisitions with Lifecare Fundraise Overview Partnership Overview • Issuance of up to 44,50,000 fully convertible • Exclusive strategic partnership with Jeena equity warrants on a preferential basis Si
Slide 9: Q3 FY26 Operational Highlights
Q3 FY26 Operational Highlights Delhi | Prashant Vihar Punjab PPP Radiology Bhopal Diagnostic Centre Imaging Project Diagnostic Centre Opened a new advanced diagnostic centre Awarded a long-term government PPP Inaugurated and commenced contract operations Expanded test menu to include advanced genomi
Slide 10: Company Overview
Company Overview Redefining Diagnostics & Pharmacy in North India Investor Presentation 9
Slide 11: Chandan at a Glance
Chandan at a Glance Chandan Healthcare Limited is one of the leading North India-based providers of diagnostic and pharmacy services, and a key entity within the Chandan Group. The Company offers a comprehensive suite of NABL/NABH-accredited pathology and radiology solutions across Uttar Pradesh and
Slide 12: Key Facts & Figures
Key Facts & Figures 20+ 18.21 Lakh Years Of Industry Experience Total Patient Count (FY25) Decision making icon 1700+ 53.98 Lakh + Team Size Total Test Conducted(FY25) NABH MIS 360 Collection Centres Accreditation For 5 centres 60+ NABL Accreditation Diagnostic Centres For 10 Labs Presence 51 Cities
Slide 13: Key Events & Achievements
Key Events & Achievements 2025 2018 Listed in Stock Exchange Won Most Innovative 2025 Crossed turnover of Healthcare Service Provider ₹ 200 Cr 2003 Started its first 2022 diagnostic centre in Crossed turnover of 20 ₹ 100 Cr Indra Nagar Lucknow 23 2003 2013 2019 2024 Incorporation of our Started its
Slide 14: Chandan Group Overview
Chandan Group Overview Chandan Group of Companies HOSPITALS DIAGNOSTICS PHARMACY PHAMACEUTICALS Chandan Healthcare Limited Chandan Pharmacy Limited Cendana Pharmaceuticals Chandan Hospital Chandan Super Private Limited Limited Speciality Limited Presence Presence Uttar Pradesh – 19 Cities Uttar Prad
Slide 15: Board Of Directors
Board Of Directors Amar Singh Asmita Singh Vinay Lamba Promoter, Chairman and Managing Director Promoter and Managing Director Non-Executive Director MBBS with 20+ years of experience in the BBA and MBA with 20+ years of marketing Marine Engineer with 10+ years of experience in healthcare industry e
Slide 16: Business Overview
Business Overview Multi-Segment Model Driving Growth Across B2C, B2B & B2G Investor Presentation 15
Slide 17: Chandan's Core Business Verticals
Chandan’s Core Business Verticals Pathology Radiology Pharmacy FY25 Revenue FY25 Revenue FY25 Revenue ₹96.50 Cr ₹ 27.80 Cr ₹ 105.80 Cr (41.94%) (12.08%) (45.98%) Investor Presentation 16
Slide 18: Balanced Business Model Across Retail, Government & Institutions
Balanced Business Model Across Retail, Government & Institutions Diversified revenue streams ensure stability, scalability, and reduced risk. B2C (Retail Diagnostics) B2B (Institutional Clients) B2G (Government PPPs) • Walk-in services across 35+ • 230+ private hospitals & clinics as • Public-Privat
Slide 19: Top Performing Centres Across Categories
Top Performing Centres Across Categories 22 Large Centres 29 Medium Centres 9 Small Centres Equipped with MRI & advanced Provide CT facilities, but no Basic healthcare & imaging for comprehensive MRI; focus on essential diagnostics without MRI/CT; diagnostics imaging services cater to Tier-2/3 regio
Slide 20: Expansive Regional Footprint Across North & Central India
Expansive Regional Footprint Across North & Central India State-wise Revenue In % The complete network comprises large, medium, and small centers and 360 sample collection centers. 29% Uttar Pradesh ₹ 230.10 Cr Uttarakhand 71% Glimpse Of Chandan’s Diagnostic Centres Large Medium Small Investor Prese
Slide 21: Enhancing Diagnostic Capabilities Through Capex
Enhancing Diagnostic Capabilities Through Capex Jankipuram, Lucknow Ashiyana, Lucknow Ayodhya, Uttar Pradesh Total capex investment: ₹24.68 Cr Total capex investment: ₹7.10 Cr Total capex investment: ₹7.10 Cr Purpose: Establishment of advanced Purpose: Diagnostic infrastructure Purpose: Setup of mul
Slide 22: Certified By India's Top Accrediting Bodies
Certified By India’s Top Accrediting Bodies Recognized For Quality Care With 5 NABH-Accredited Centres And 10 NABL-Crtified Labs. NABH Indira Nagar NABH MKP Chowk NABH Prayagraj NABL Indira Nagar NABL MKP Chowk UK NABL Karachi Khana Investor Presentation 21
Slide 23: Technology-Driven Healthcare at Chandan
Technology-Driven Healthcare at Chandan • 90+ Specialties 100K+ Downloads Available On • 24x7 Access On Play store IOS • One App for All Healthcare Needs Chandan 24x7 Digital-first platform strengthening customer loyalty & operational efficiency Unified Platform Diagnostics, Pharmacy & Doctor Consul
Slide 24: Affordable Healthcare, Strengthened Loyalty
Affordable Healthcare, Strengthened Loyalty Chandan Family Loyalty Card An integrated healthcare membership programme offering patients savings, convenience & holistic family coverage. Key Privileges Strategic Impact for Chandan • Up to 70% savings on Preventive Health • Boosts customer loyalty & ch
Slide 25: Pharmacy Segment – Strong Complement To Diagnostics
Pharmacy Segment – Strong Complement To Diagnostics Pharmacy contributes ₹ 105.8 Cr (~46% of Chandan’s FY25 revenue), with a strong retail-driven model, steady institutional demand, and synergy with diagnostic services. Service Strengths In % In % Consumer Category Wise Sales Product Category Wise S
Slide 26: Key Strengths Driving Sustainable Growth
Key Strengths Driving Sustainable Growth Integrated Diagnostic Platform Digital Ecosystem with Strong Adoption Offers 3,500+ pathology and radiology tests 100K+ downloads of Chandan 24x7 App under NABL/NABH-accredited infrastructure offering e-pharmacy, doctor consultations, test bookings, and digit
Slide 27: Expanding Footprint Across India
Expanding Footprint Across India Network Expansion Plan Expansion Highlights • Targeting a network of 100 labs across 17 states over • New States: Entry into Delhi, Madhya Pradesh & the next 3 years Chhattisgarh • Expanding presence through 1,000 franchises in the • Strengthening Presence: Deepening
Slide 28: Future Roadmap: Chandan Healthcare
Future Roadmap: Chandan Healthcare Maintaining Capital Efficiency: Unlocking Future Value: Fund growth primarily through Explore value unlocking internal accruals; raise capital via pharmacy selectively. restructuring once diagnostics achieve scale. Leveraging Technology for Differentiation: Deploy
Slide 29: Industry Overview
Industry Overview Healthcare Demand Rising Across India’s Metro & Tier-2/3 Cities Investor Presentation 28
Slide 30: Indian Healthcare Industry Overview
Indian Healthcare Industry Overview The Indian Healthcare Sector Is Entering Its Golden Decade. The Indian healthcare market is Indian Healthcare Industry Size in projected to grow from approximately (US$ Billion) US$ 367 billion by 2023 to 700 US$ 638 billion by 2025, representing a 638 Public heal
Slide 31: Indian Diagnostics Sector Overview
Indian Diagnostics Sector Overview Market Size & Growth • Diagnostics industry expected to grow from US$13 Billion (FY23) to US$25 Billion (FY28) at a 14% CAGR. Indian Diagnostic Market (US$ Billion) • Growth driven by rising chronic diseases, ageing population, demand for preventive tests, and wide
Slide 32: Financial Overview
Financial Overview Consistent Growth Backed by Scale, Efficiency & Expansion Investor Presentation 31
Slide 33: Financial Highlights
Financial Highlights Year On Year Revenue Growth Fixed Asset Turnover Interest Coverage Return on Equity 30.57% 2.86 Times 7.95 Times 27.08% Year on Year Profit Return on capital Growth Employed Debt to Equity Book Value 36.17% 29.34% 0.39 Times ₹ 50.14 Investor Presentation 32
Slide 34: Key Financial Highlights
Key Financial Highlights (All Amount In ₹ Cr & Margins In %) Total Income EBITDA EBITDA Margin PAT PAT Margin 50 27.00% 25 27.00% 232.17 43.38 22.17 45 22.00% 22.00% 40 18.69% 20 177.81 35 15.53% 17.00% 17.00% 16.27 27.62 30 137.03 12.00% 15 12.00% 25 6.95% 7.00% 9.22% 9.63% 7.00% 20 10 15 2.00% 2.0
Slide 35: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement (In ₹ Cr) Particulars FY23 FY24 FY25 Revenues 136.89 176.59 230.12 Other Income 0.14 1.22 2.05 Total Income 137.03 177.81 232.17 Raw Material Expenses 64.71 80.85 107.62 Employee Costs 25.49 35.42 38.86 Other Expenses 37.30 33.92 42.31 Total Expenditure 127.51 15
Slide 36: Consolidated Balance Sheet
Consolidated Balance Sheet (In ₹ Cr) Equities & Liabilities FY23 FY24 FY25 Assets FY23 FY24 FY25 Equity 20.00 20.00 24.45 Non-Current Assets Reserves And Surplus 2.76 21.16 98.15 Fixed assets 32.56 48.49 80.45 Total Equity 22.76 41.16 122.60 Non-Current Investments 4.54 3.38 1.15 Non-Current Liabili
Slide 37: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement (In ₹ Cr) Particulars FY23 FY24 FY25 Cash Flow from Operating Activities 4.50 1.12 -29.05 Cash Flow from Investing Activities -6.49 -14.83 -35.75 Cash Flow from Financing Activities 2.46 15.57 67.11 Net Increase in Cash & Cash Equivalents 0.47 1.86 2.31 Investor Pres
Slide 38: Key Ratios
Key Ratios ROE ROCE (In %) EPS Book value (In ₹) 40.00% 92.00% 35.04% 35.00% 82.00% 29.34% 50.14 30.00% 72.00% 25.00% 62.00% 52.00% 47.60% 20.00% 42.00% 15.51% 27.08% 15.00% 20.58 32.00% 15.03 10.78 10.00% 22.00% 8.14 13.15% 1.68 5.00% 12.00% 2.00% 0.00% FY23 FY24 FY25 FY23 FY24 FY25 (In Times) (In
Slide 39: Stock Data
Stock Data As On 14-02-2026 As On 31-12-2025 NSE (CHANDAN | INE0B2N01016) Share Holding Pattern Share Price (₹) 283.85 Market Capitalization (₹ Cr) 694.07 50.53% Promoter & Promoter Group No. of Shares Outstanding 2,44,52,064 Public Face Value (₹) 10.00 49.47% 358.00 – 140.00 52-week High-Low (₹) Sh
Slide 40: Investment Rationale
Investment Rationale Integrated Diagnostics Chain offering both pathology and radiology services under one roof, driving patient stickiness and cross-selling opportunities. Widespread Presence with operations across 51+ cities in 13 states, enabling deep regional penetration and first-mover advantag
Slide 41: Thank You
Thank You Chandan Healthcare Limited Biotech Park, Kursi Road, Lucknow 226021 U.P. Email: care@chandan.co.in Phone: 08069366666 Website: www.chandandiagnostic.com Kirin Advisors Private Limited 713-B, Lodha Supremus II, Wagle Estate, Thane West – 400 604 E-mail: info@kirinadvisors.com Phone: 022 410